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Abstract
Background: The aged brain exhibits a loss in gray matter and a decrease in spines and synaptic densities that may
represent a sequela for neurodegenerative diseases such as Alzheimer’s. Membrane/lipid rafts (MLR), discrete regions of the
plasmalemma enriched in cholesterol, glycosphingolipids, and sphingomyelin, are essential for the development and
stabilization of synapses. Caveolin-1 (Cav-1), a cholesterol binding protein organizes synaptic signaling components within
MLR. It is unknown whether loss of synapses is dependent on an age-related loss of Cav-1 expression and whether this has
implications for neurodegenerative diseases such as Alzheimer’s disease.
Methodology/Principal Findings: We analyzed brains from young (Yg, 3-6 months), middle age (Md, 12 months), aged (Ag,
.18 months), and young Cav-1 KO mice and show that localization of PSD-95, NR2A, NR2B, TrkBR, AMPAR, and Cav-1 to
MLR is decreased in aged hippocampi. Young Cav-1 KO mice showed signs of premature neuronal aging and degeneration.
Hippocampi synaptosomes from Cav-1 KO mice showed reduced PSD-95, NR2A, NR2B, and Cav-1, an inability to be
protected against cerebral ischemia-reperfusion injury compared to young WT mice, increased Ab, P-Tau, and astrogliosis,
decreased cerebrovascular volume compared to young WT mice. As with aged hippocampi, Cav-1 KO brains showed
significantly reduced synapses. Neuron-targeted re-expression of Cav-1 in Cav-1 KO neurons in vitro decreased Ab
expression.
Conclusions: Therefore, Cav-1 represents a novel control point for healthy neuronal aging and loss of Cav-1 represents a
non-mutational model for Alzheimer’s disease.
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Introduction
Cognitive decline is emerging as one of the greatest health
problems in the elderly population [1,2]. Age alone increases the
risk of stroke, Alzheimer’s disease (AD), and other forms of
dementia [2]. The risk of AD increases 14-fold between the ages of
65–85, and affects almost 47% over the age of 85 [3].
Multiple signaling pathways regulate neuronal survival and
growth to facilitate the formation of synapses and this signaling is
altered with age [4,5,6,7]. Synapses are essential for learning,
memory and the development of neurons in the CNS [8].
Receptors and associated proteins aggregate to mold and shape
post-synaptic densities in order to permit high fidelity signal
transduction leading to rapid regulation of neuronal function
[9,10,11]. Understanding the basic pathophysiological mecha-
nisms of cognitive decline and how the subcellular organization of
signaling molecules is altered with cognitive decline could
potentially yield novel therapeutic targets for neuronal aging and
neurodegeneration.
Cholesterol is a major lipid component of synapses and a
limiting factor in synapse development, synaptic activity, and
neurotransmitter release [12]. Age-related impairments in the
biosynthesis, transport, or uptake of cholesterol by neurons in the
CNS may adversely affect development, plasticity, and synaptic
circuitry associated with neurodegenerative diseases [13,14,15,
16,17]. Membrane lipid rafts (MLR), discrete regions of the
plasma membrane enriched in cholesterol, glycosphingolipids
and sphingomyelin, are essential for synapse development,
stabilization, and maintenance [12,18]. Moreover, caveolin-1
(Cav-1), a cholesterol binding and resident protein of MLR
[19,20,21], organizes and targets synaptic components of the
neurotransmitter and neurotrophic receptor signaling pathways
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15697to MLR [e.g., NMDAR, AMPAR, TrkR, Src Family Kina-
ses (SFK)] [22,23,24,25,26,27]. Additionally, neurotransmitter
and neurotrophic receptors are found within MLR in growth
cones, a finding that has major implications for neuronal plasticity
[11,28].
Early-onset AD, which afflicts individuals prior to 60–65 years
of age, is known to be caused by mutations in three genes: amyloid
precursor protein (APP), presenilin-1, and presenilin-2 [29]. MLR
and cholesterol play a protective role against APP processing and
amyloid-b (Ab) toxicity [13,14,16,30,31,32,33]. Cav-1 KO mice
develop CNS pathology similar to AD, such as altered
NMDA receptor signaling, motor and behavioral abnormalities,
increased ischemic cerebral injury, impaired spatial memory,
and cholinergic function [27,34,35,36]. Whether MLR, Cav-1
expression, and the organization of pro-survival and pro-growth
signaling mechanisms are altered in neurodegenerative states (age-
related dementia and AD) has yet to be investigated. The present
study tested whether 1) Cav-1 organizes synaptic signaling
components in neuronal MLR and synaptosomes, 2) the
localization of synaptic signaling components to neuronal MLR
and synaptosomes is reduced in brains from aged wild-type and
young Cav-1 KO mice, and 3) brains from Cav-1 KO mice
develop a neuropathological phenotype similar to Alzheimer’s
disease.
Results
PSD-95, NR2A, NR2B, and Cav-1 protein expression is
decreased in middle aged and aged hippocampus
Hippocampi were isolated from brains of C57BL/6J mice (wild-
type, WT) at 3–6 months (young), 12 months (middle aged), and
.18 months (aged). Immunoblots of hippocampal homogenates
showed a significant reduction in PSD-95 (n=6, p=0.0001 vs
Md, p=0.01 vs Ag), NR2A (n=6, p=0.02 vs Md, p=0.02 vs Ag),
NR2B (n=6, p=0.02 vs Md, p=0.04 vs Ag), TrkB (n=6,
p=0.009 vs Md, p=0.03 vs Ag), and Cav-1 (n=6, p=0.008 vs
Md, p=0.04 vs Ag) in hippocampi from middle aged and aged
mice when compared to young mice (Figure 1). These data
demonstrate an age-dependent reduction in synaptic signaling
components and Cav-1 in the hippocampus.
Age-related decreases in synaptic signaling components
from MLR
MLR play a role in stabilizing synapses in the mammalian brain
[12,18], therefore we performed sucrose density fractionation of
whole brain homogenates from young, middle aged and aged WT
mice to purify MLR. Immunoblots showed buoyant fractions from
young brains contained the majority of PSD-95 (n=5, p=0.03 vs
Ag), NR2A (n=5, p=0.04 vs Md, 0=0.0005 vs Ag), NR2B
Figure 1. Hippocampal homogenates show an aged dependent reduction in NR2A, NR2B, PSD-95, and Cav-1. Hippocampi were
isolated from the brains of C57BL/6J mice at 3–6 months (young, Yg), 12 months (middle aged, Md), and 24 months (aged, Ag). Immunoblot
and densitometric analysis demonstrated a significant reduction in PSD-95, NR2A, NR2B, TrkBR, and Cav-1 in the Md and Ag hippocampus compared
to Yg.
doi:10.1371/journal.pone.0015697.g001
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Ag), TrkB (n=5, p=0.005 vs Ag, 0=0.003 Md vs Ag), and Cav-1
(n=5, p=0.004 vs Ag, 0=0.004 Md vs Ag) (Figure 2A,B). In
contrast, buoyant fractions from the middle aged and aged brains
showed a significant reduction in synaptic signaling components
compared to Yg, with the majority of the proteins detected in
heavy fractions, 11 and 12 only. Cav-1 (C) and PSD-95 (P) co-
immunoprecipitated with NR2A, NR2B, AMPAR, and TrkB in
the buoyant fractions of Yg mice, with decreased detection in Md
and Ag (Figure 2C). These data demonstrate an age-dependent
decrease in synaptic signaling components including Cav-1 from
MLR and PSD-95 immunoprecipitation of MLR.
Previous work has shown that MLR facilitate neuronal synapse
formation [12,18]. We sought to confirm whether the age-related
decrease in synaptic signaling components in MLR also occurred
in synaptosomes purified from hippocampi of Yg, Md, and Ag WT
mice. Immunoblots and PSD-95 immunoprecipitates of synapto-
somes from Md and Ag mice showed a decrease in PSD-95,
NR2A, NR2B, AMPAR, and Cav-1 compared to Yg (Figure 2D).
Assessment of membrane fluidity of synaptosomes isolated from
whole brain of Yg and Ag mice using electron paramagnetic
resonance showed that membranes of Ag mice had significantly
lower membrane order parameter (greater fluidity) than mem-
branes from Yg (n=5, p=0.001) (Figure 2E). These findings
suggest that age-related decrease in MLR and Cav-1 expression
are associated with increased membrane fluidity (i.e., increased
liquid-disordered phase) [37].
Young Cav-1 KO mice demonstrate accelerated aging
and neurodegeneration
Loss of synaptic proteins and neuronal preconditio-
ning. Cav-1 expression is decreased in hippocampi and
buoyant fractions (i.e., MLR) from Ag mice (Figure 1 and 2), we
therefore assessed whether Yg Cav-1 KO mice display reduced
synaptic protein expression. Hippocampal synaptosomes from Yg
Cav-1 KO mice showed a similar pattern to Ag WT mice, reduced
protein expression of PSD-95, NR2A, NR2B, and AMPAR
(Figure 3A). Similar to aged WT mice, PSD-95
immunoprecipitation of hippocampal synaptosomes from Cav-1
KO mice showed minimal detection of PSD-95, NR2A, NR2B,
and AMPAR.
We next sought to determine whether neuroprotection against
ischemic injury is absent in Yg Cav-1 KO mice. To achieve this
we performed an ischemic preconditioning protocol. Ischemic
preconditioning (IPC), a phenomenon wherein sublethal ischemia
protects the brain from a subsequent lethal ischemic event, is
absent in brains from aged animals [38,39] and in neurons in vitro
that have reduced or no Cav-1 expression [27]. We show here for
the first time that Cav-1 KO mice show a similar reduction in
neuroprotective signaling components to that exhibited by brains
from aged WT mice. IPC significantly protected CA1 neurons
against lethal ischemia in WT mice (n=7, p=0.0072 vs LI)
(Figure 3B-iv, C). There was no significant protection in CA1
neurons from Cav-1 KO mice subjected to IPC prior to LI
(Figure 3B-viii, C), demonstrating an inability to induce IPC in
these mice. In terms of expression and function of synaptic
signaling components, young Cav-1 KO mice resemble aged WT
mice.
Early on-set of AD-like phenotype
Previous work has shown that Cav-1 and MLR can regulate
amyloidogenic processing of APP [30]. Therefore, we assessed
whether brains from Cav-1 KO mice exhibit pathological signs
indicative AD. Amyloid-b (Ab) (n=4, p=0.005) and P-Tau[T181]
(n=4, p=0.02) were significantly elevated in hippocampal
homogenates from Yg Cav-1 KO mice (Figure 4A). Immunoflu-
orescence microscopy demonstrated that Yg Cav-1 KO mice had
increased Ab staining in Nissl positive neurons in the CA3 (n=3,
p=0.006) and CA1 (n=3, p=0.04) region of the hippocampus
compared to WT mice (Figure 4B). Hippocampi from Cav-1 KO
mice showed a 20–25% reduction in cerebrovascular volume
(n=4, p=0.001) (GSA, blood vessel marker - Figure 4C).
Toludine blue staining of the hippocampus showed a large
reduction in neurons within the dentate gyrus and CA1 regions of
Yg Cav-1 KO mice (Figure 5A-i, A-ii) compared to Yg (Figure 5C-
i, C-ii) and Ag (Figure 5B-i, B-ii) WT mice. In addition, there
appeared to be more glia and glial scar formation within the
dentate gyrus of Cav-1 KO mice as indicated by the darker gray
cell bodies intermixed with the neurons (Figure 5A-i, A-ii). Young
Cav-1 KO show increased astrogliosis (n=4, p=0.0006) (GFAP,
astrocyte marker – Figure 5D). Flouro-JadeHB staining demonstrat-
ed little neuronal degeneration and well-organized astrocytes in
the CA1 from Yg WT mice when compared with Yg Cav-1 KO
mice, which showed disorganized astrocytes and areas of potential
plaque development. Due to their shorter life spine [40], obtaining
Ag Cav-1 KO mice is difficult. We here show that the CA1 region
from 12 month Cav-1 KO mice had large bright, entangled green
fluorescence with red fluorescent (Nissl) neurons and severely less
organized astrocytes, demonstrating increased neuronal degener-
ation (Figure 5E).
There is a reduction in synaptic proteins from hippocampal
synaptosomal membranes, we therefore assessed whether Cav-1
KO mice exhibit changes in total hippocampal synapses. Routine
electron microscopy (EM) revealed a significant reduction in
hippocampal synapses (i.e., post synaptic densities) in both Cav-1
KO (n=6, p=0.002) (Figure 6C) and Ag (n=6, p=0.02)
(Figure 6B) mice compared to Yg (Figure 6A). In addition, Cav-
1 KO mice displayed unorganized cytoskeletal assemblage (arrow
heads) within dendrites (d, asterisks)( Figure 6F) and elevated
astocyte presence (arrows) compared to brains from Ag
(Figure 6E) and Yg WT mice (Figure 6D), the latter displaying
normal cytoskeletal organization (arrow heads) within dendrites
(d). These data indicate that Cav-1 KO mice develop pathological
changes at 3 months of age consistent with aging and AD mouse
models.
Re-expression of Cav-1 in Cav-1 KO neurons decreases Ab
Cav-1 KO mice demonstrate pathology similar to AD such as
elevated Ab production in the hippocampus. We tested whether
neuron-targeted re-expression of Cav-1 in primary Cav-1 KO
neurons would decrease Ab expression. We generated a viral
vector that contains a neuron-specific synapsin promoter upstream
of Cav-1 cDNA (SynCav1)( Figure 7A). Increasing doses of SynCav1
for 72 hr proportionally increased Cav-1 expression and reduced
Ab (Figure 7B). Six separate neuronal cultures from Cav-1 KO
mouse brains were transfected with SynGFP (control vector) or
SynCav1, and SynCav1 significantly reduced Ab expression (n=6,
p=0.002) after 72 hr (Figure 7C).
Discussion
The present study is the first to demonstrate that the cholesterol
binding and MLR resident protein, Cav-1, complexes with
synaptic proteins in the CNS, and that this organization is
disrupted with age. Furthermore, this study is the first to
demonstrate that loss of Cav-1 in a transgenic mouse model
produces neuropathology similar to that exhibited with AD, i.e.,
Ab production, elevated astrogliosis, reduced cerebrovasculature
Decreased Caveolin-1 and Neurodegeneration
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only are MLR and Cav-1 essential for maintaining and stabilizing
proper synaptic signaling [27] and neuroprotection against
cerebral ischemia, but they also may serve to slow the
amyloidogenic process of APP seen in AD brains. Lastly, Cav-1
KO mice may serve as the first non-mutational model of AD.
It is essential to understand the basic neural mechanisms of
synapse formation and stabilization in order to identify potential
therapeutic targets for facilitating neuronal regeneration and
recovery of neuronal networks in the aged and injured brain.
Traditionally synapses and MLR are considered separate
subcellular structures, yet they both contain identical physical
characteristics that are essential such as cholesterol, glycosphin-
golipids, sphingomyelin, and other saturated fatty acid containing
lipids (GM1 gangliosides, palmitic acid) as well as signaling
components [22,23,24,25,26,27]. Growing evidence supports the
role for free cholesterol and MLR in neuronal synaptic formation,
signaling and protection [12,18,27,41,42,43]. Because free cho-
lesterol directly affects Cav-1 expression, factors that alter
intracellular cholesterol also change Cav-1 expression [44,45,46].
Specifically, brain derived neurotrophic factor (BDNF), a
neurotrophin essential to synaptic function and development
[47] which facilitates of long-term potentiation[48,49], elicits
cholesterol biosynthesis and increased MLR and Cav expression in
cortical and hippocampal neurons.[50] Furthermore, MLR are
critical for growth cone expansion, neurite outgrowth, and axonal
branching and guidance [11,51,52]. Therapeutic approaches to
promote axonal regeneration and synapse formation after spinal
chord injury use a MLR marker, cholera toxin B, as a direct
indicator of axonal regeneration and de novo synapse formation
[53,54]. Moreover, there exists increasing evidence that disruption
or alterations of neuronal MLR and intracellular cholesterol can
be neurotoxic and even contribute to enhanced neuronal
vulnerability to Ab [13,14,33], demonstrating the importance of
these distinct microdomains for proper pro-survival neuronal
signaling [27,41,55,56,57]. When Cav-1 was over-expressed in b-
secretase expressing cells, amyloid precursor protein and b-
secretase localization to MLR resulted in decreased Ab produc-
tion, suggesting a protective role by Cav-1 and MLR against Ab
toxicity [30,31,32,58]. Interestingly the fatty acid content in MLR
(a.k.a. detergent-resistant membranes, or DRMs) isolated from
synaptic endings is altered in aged animals [59]. This result is
consistent with our findings that membrane fluidity in synapto-
somal membranes is increased in aged brains. Age-related
physiochemical changes to distinct biological membranes such as
MLR could be responsible for changes in Cav-1 expression and
loss of synaptosomal pro-survival signaling components with age.
Our results demonstrate that loss of Cav-1 results in accelerated
aging. Cav-1 KO mice have a shortened life span [40]. Two
pathophysiologies altered with aging are vulnerability to ischemic
stress and progression of AD. IPC is a phenomenon whereby brief
ischemia, which does not injure neurons, renders the brain less
vulnerable to subsequent ischemic injury [27,60,61,62,63,64]. IPC
activates endogenous signaling pathways that are neuroprotective,
and this neuroprotection is lost in the aged brain [38,39]. The
underlying mechanism for the lack of ischemic tolerance in the
aged brain is not clear. Signaling pathways in neurons are severely
compromised with age. Specifically, post-synaptic molecules such
as glutamate receptors, neurotrophin receptors and pro-survival
signaling cascades (i.e., kinase activation and cAMP production)
decrease significantly with age [65,66,67,68,69]. It is therefore
possible that the organization, and thus efficacy of signaling
pathways that produce tolerance is severely limited in the aged
brain. We show in young Cav-1 KO mice that preconditioning is
absent, suggesting a link between the loss of MLR and disrupted
organization of pro-survival signaling.
In addition to loss of IPC, Cav-1 KO mice also exhibit
characteristics consistent with AD. Cerebrovascular changes and
increased astrogliosis [70,71,72,73,74] could also be a contributing
factor to the absence of ischemic tolerance [75] as well as the AD
phenotype exhibited by young Cav-1 KO mice. Upregulation of
endogenous protective signaling in aged neurons through neuron-
targeted Cav-1 expression might reduce the vulnerability of the
aged brain even in the presence of reduced cerebrovascular
volume. Neuron-targeted Cav-1 re-expression/over-expression
offers the novel possibility of re-establishing the fidelity of
neuroprotective signaling that is lost with advanced age or in
other forms of neurodegeneration (i.e., dementia, Alzheimer’s
disease, depression, Parkinson’s disease).
In summary, these findings demonstrate an important role for
Cav-1 and MLR in organizing synaptic pro-survival signaling
components that are essential for neuroprotection against ischemic
injury, neuronal regeneration, and maintaining synapse stabiliza-
tion and formation. Cav-1 may be a control point for neurological
aging. Further understanding of how MLR and Cav-1 serve as a
nexus for pro-survival and pro-growth signaling components may
not only provide potential therapeutic targets for the preservation
of neuronal function, but may also yield tools that could augment
the brain’s capacity to reorganize its neuronal networks following
injury or during late stages of neurodegenerative diseases such as
AD and other forms of dementia.
Materials and Methods
All studies performed on animals were approved by Veteran
Affairs San Diego Institutional Animal Care and Use Committee
(Protocol#: 08-035 and ID#:1141788) and conform to relevant
National Institutes of Health guidelines.
Figure 2. PSD-95, NR2A, NR2B, AMPAR, TrkBR, and Cav-1 are abundantly detected in buoyant fractions (BF) from young mouse
brains homogenates, yet are less abundant BFs from middle aged and aged brains. Sucrose density fractionated was performed on brains
from three different age groups of C57BL/6J mice: young (Yg, 3–6 months), middle aged (Md, 12 months), and aged (Ag, .18 months). Immunoblot
analysis detected the majority of PSD-95 (post-synaptic density marker), NR2A, NR2B, AMPAR, TrkBR, and Cav-1 in buoyant fractions 4 and 5 (BFs)
isolated from Yg brains (A). In contrast, the Md and Ag brains exhibited a drastic reduction in these synaptic signaling components, with the majority
of these proteins detected in heavy fractions 11 and 12 (HFs) only. Densitometric analysis of the data is represented in B.( C) Cav-1 (C) and PSD-95 (P)
immunoprecipitates pulled down NR2A, NR2B, AMPAR, and TrkB in the buoyant fractions of Yg mice, with decreased detection in Md and Ag.
(D) Immunoblot analysis detected a significant decrease in PSD-95 (post-synaptic density marker), NR2A, NR2B, AMPAR, and Cav-1 in hippocampal
synaptosomes from Md and Ag brains compared to Yg. PSD-95, NR2, NR2B, AMPAR, and Cav-1 decreased in PSD-95 immunoprecipitates of Md, and
Ag synaptosomes compared to Yg. (E) Electron paramagnetic resonance (EPR) was performed on synaptosomal membranes from brains of C57BL/6J
mice: young (Yg, 3–6 months) and aged (Old, .18 months). Membrane localized spin labels 5-doxylstearic acid (5-DSA) probes changes in the
neuronal membrane fluidity closer to the membrane surface. Lineshape analysis of 5-DSA spin label using the indicated parameters revealed that
neuronal membrane of aged mice exhibit significantly lower order parameter (i.e. increased fluidity) than young animals. Aged membranes were
8.561.2% more fluid than young membranes (F(1,10)=223.5, p=0).
doi:10.1371/journal.pone.0015697.g002
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15697Figure 3. Ischemic preconditioning (IPC) does not occur in Cav-1 KO mice. (A) Hippocampal synaptosomes from Cav-1 KO (Yg) showed a
similar pattern to Ag, with a decrease in PSD-95, NR2A, NR2B, and AMPAR. PSD-95 IPs of Cav-1 KO synaptosomes revealed minimal detection in PSD-
95, NR2A, NR2B, and AMPAR. (B) WT or Cav-1 KO mice were subjected to 3 min (ischemic preconditioning, IPC) and/or 12 min (lethal ischemia, LI)
induced by bilateral carotid artery occlusion (BCAO). Intact neurons in CA1 hippocampal (HP) region were counted from Cresyl Violet stained paraffin
fixed sections. IPC (3 min, BCAO) significantly protected CA1 neurons against LI (12 min, BCAO) in WT mice (iv). There was a significant increase in
CA1 neuronal death in Cav-1 KO animals subject to IPC (viii) versus WT IPC + LI. Representative Cresyl Violet stained CA1 hippocampal images from
(i) WT sham, (ii) WT IPC, (iii) WT LI, and (iv) WT IPC and (v) Cav-1 KO sham, (vi) Cav-1 KO IPC, (vii) Cav-1 KO LI, and (viii) Cav-1 KO IPC. Quantitation of
images is presented by the graph.
doi:10.1371/journal.pone.0015697.g003
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Neonatal mouse neurons were isolated using a papain
dissociation kit (Worthington Biochemical, Lakewood, NJ) as
previously described [27]. Neurons were cultured in Neuobasal A
media supplemented with B27 (2%), 250 mM GLUTMax1, P/S
(1%). Cells were cultured on poly-D-lysine/laminin (2 mg/cm
2)
coated plates at 37uCi n5 %C O 2 for 4 d prior to transfection with
lentiviral vectors. Cav-1 cDNA was cloned in our laboratory and
given to Dr. Atushi Miyanohara at the UCSD Viral Vector Core.
Dr. Miyanohara successfully generated a lentiviral vector contain-
ing the synapsin promoter up-stream of the Cav-1 gene (SynCav1).
SynGFP was used as control vector. Titer for both vectors was
approximately 10
9 infectious units (i.u.) per ml.
Sucrose-density fractionation
Membrane/lipid rafts were isolated from adult brain and
neurons using detergent-free methods. Tissue and cells were
homogenized in sodium carbonate (150 mM, pH 11.0), and then
sonicated with three cycles of 20 sec bursts with 1 min incubation
on ice. Homogenate (1 mL) was mixed with 1 mL of 80% sucrose
to generate 2 mL of 40% sucrose. Above the 40% layer, 6 mL of
35% and 4 mL of 5% sucrose were carefully layered. The mixture
was centrifuged at 175,000 g using SW41Ti rotor (Beckman) for
3 h at 4uC. Samples were removed in 1 ml aliquots and the
membrane/lipid rafts are found in buoyant fractions 4–5 (5/35%
interface).
Synaptosomal membrane preparation
Neuronal cells or brain tissue were homogenized in 5 ml of
solution A [0.32 M sucrose (34 g/500 ml), 0.5 mM CaCl2
(36 mg/500 ml), 1 mM NaHCO3 (42 mg/500 ml), 1 mM MgCl2
(102 mg/500 ml)] containing protease and phosphatase inhibitors
with 12 strokes of a 19684 mm tissue grinder (Potter Elvehjem,
plastic coated) at 800 r.p.m. Samples were then subjected to
centrifugation for 10 min at 1000 g at RT to remove large debris.
Centrifugation 1 involved careful layering of the supernatant
onto 4 ml of 1.2 M sucrose (41 g/100 ml or 41% sucrose) in a
SW41 centrifuge tube (Beckman) and then spun at 160,000 g for
15 min (or 33,000 r.p.m. with SW41 rotor). The synaptosomes
were found at the interface between the 1.2 M and 0.32 M sucrose
layers. The synaptosomes were then mixed with 4 ml of 0.32 M
sucrose and then carefully layered onto 4 ml of 0.8 M sucrose (or
27% sucrose) in a fresh centrifuge tube for second major
centrifugation. Centrifugation 2 consisted of spinning the
sample at 160,000 g for 15 min (33,000 rpm with SW41 rotor)
generating a pellet enriched in the synaptosomes. The pellet was
then resuspended in 1 ml of neuronal lysis buffer containing
protease and phosphatase inhibitors and used for immunoprecip-
itation and/or immunoblot analysis.
Determination of synaptosomal membrane fluidity using
electron paramagnetic resonance (EPR)
Hydrocarbon chain mobility was measured using fatty acid spin
labeling EPR analysis using 5-nitroxyl stearate (5-DSA, Aldrich) as
a spin probe [76,77]. The number designation indicates the
relative position of the nitroxide on the stearic acid relative to the
polar carboxylic group. In the case of 5-DSA, the spin probe is
firmly held in place by the head groups of the lipids, which is
reflected in broad EPR lines. Synaptosomes from young (3–6 m)
and aged (.18 m) mice were isolated as described previously [78].
Freshly prepared synaptosomal protein (0.1–0.2 mg) was incubat-
ed for 15 minutes with 5-DSA (1 mM final concentration) in
synaptosomal buffer (120 mM NaCl, 4.7 mM KCl, 2.2 mM
CaCl2, 1.2 mM MgCl2, 25 mM HEPES, 1.2 mM MgSO4,
1.2 mM KH2PO4, 10 mM glucose) at 25uC. The mixture was
then loaded into a 50 ml-glass capillary and inserted into the EPR
cavity of a MiniScope MS200 Benchtop spectrometer (Magnet-
tech, Berlin), maintained at 37uC, where the EPR spectra
registered. EPR conditions were the following: microwave power,
5 mW; modulation amplitude, 2 G; modulation frequency,
100 kHz; sweep width, 150 G centered at 3349.0 G; scan rate,
7.5 G/s, with each spectrum representing the average of 5 scans.
The fluidity parameters T|| and TH are defined in Figure 2E
and are used to calculate the order parameter as previously
described [76,77].
In vivo BCAO (bilateral carotid artery occlusion) model of
neuronal preconditioning
Male C57BL/6J and Cav-1 KO mice were anesthetized with
isoflurane. After endotracheal intubation, the lungs were mechan-
ically ventilated with 1.5% isoflurane in 30% O2, balanced N2.
Pericranial temperature was controlled at 37uC. Via a pre-tracheal
incision,the carotid arteries and the basilar artery wereexposed and
a temporary clip was applied to the basilar artery. Thereafter,
preconditioning (PC) was induced by occlusion of the carotid
arteries. The clips were removed after a defined interval (3 min for
PC and 10 min for lethal ischemia), the wounds were infiltrated
with 0.25% bupivacaine and the anesthetic was discontinued. Upon
resumption of spontaneous ventilation, the endotracheal tube was
removedand the animalsweretransferredto the animalcare facility
4 hr post extubation. Animals underwent transcardiac perfusion
with heparinized saline followed by buffered paraformaldehyde.
The brains were removed and the extent of injury to the CA1 sector
of the hippocampus was determined by Cresyl violet staining.
Routine and immunoelectron microscopy
Brains were transcardially perfusion fixed with standard
Karnovsky’s fix, 4% paraformaldehyde, 1% gluteraldehyde,
0.1 M cacodylate buffer with 5 mM CaCl2. PND5-7 animals
were fixed with 2% paraformaldehyde, 2.5% glutaraldehyde,
0.1 M cacodylate buffer and 5 mM CaCl2 to prevent tissue
artifacts. Hippocampi were dissected from whole brains after 24 h
and 400 mm vibratome slices prepared and re-fixed an additional
24 h. Brains were blocked (i.e., dissected) to include hippocampal
areas, one hemisphere for sagittal orientation, and one hemisphere
for coronal. Blocks were re-fixed for an additional 24 h followed
by post-fixation with 1% OsO4 in 0.1 M cacodylate buffer, en bloc
stained with uranyl acetate and embedded with flat orientation to
locate appropriate hippocampal regions of interest. Each block
was thick sectioned, stained with toludine blue, and re-trimmed to
Figure 4. Ab, A4 protein, and P-Tau(T181) are elevated in the hippocampus of young Cav-1 KO mice. (A) Hippocampal homogenates
from WT (3 m) and Cav-1 KO (Cav-1 KO, 3–6 m) C57Bl/6J mice were immunoblotted for Ab and phosphorylated Tau (P-Tau[T181]), and GAPDH. Ab and
P-Tau[T181] were significantly elevated in young Cav-1 KO hippocampal homogenates. (B) Immunofluorescence microscopy showed that Cav-1 KO
CA1 region of the hippocampus displayed elevated Ab staining (green) overlapping with Nissl positive neurons (red) as indicated by yellow
fluorescence. Quantitation of the data is represented in the graph. (C) Cryostat sections (50 mm) of mouse hippocampus were stained with lectin GSA
(Griffonia simplicafolia) to label blood vessels. There was a 20–25% reduction in overall area occupied by blood vessels in Cav-1 KO. Quantitation of
the data is represented in the graph (right).
doi:10.1371/journal.pone.0015697.g004
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PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15697Figure 5. Cav-1 KO mice exhibit enhanced astrogliosis and neuronal degeneration. (A–C) Light microscopic image displaying 0.5 mm thick
hippocampal sections of Cav-1 KO (A-i, A-ii), aged (B-i, B-ii), and young (C-i, C-ii) stained with toludine blue. There is a drastic reduction in neurons
within the dentate gyrus (large arrow heads) and CA1 regions (arrows) of young Cav-1 KO mice compared to young and aged WT. In addition, there
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(70 nm sections) were stained with uranyl acetate and lead nitrate
for contrast and observed on the electron microscope [JEOL 1200
EX-II (Tokyo, Japan)] equipped with a digital camera system. 25
random low magnification micrographs of the stratum radiatum
were obtained from each specimen. Micrographs were analyzed
for the quantity of synapses and for synapse abnormalities
(reduction or changes in synapse and dendritic filopidal spine
morphology, i.e., degradation of cytoskeletal architecture). The
dendritic profiles were characterized by abundant organelles such
as mitochondria and endoplasmic reticulum and frequent contacts
from vesicle-filled axon terminals. Spine synapses were identified
by an electron dense region associated with vesicles pre-
synaptically and that lacked cellular organelles or contained a
spine apparatus (as indicated by cytoskeletal architecture) with
post-synaptic densities as described previously [79,80,81,82].
Approximately 25 electron micrographs (3350 mm
2) per animal
were analyzed in a blinded fashion for total synapse number per
area (synapse #/3350 mm
2).
Generation of SynCav1 construct
To link the neuron-specific synapsin (Syn) promoter with the
Cav1 cDNA, XbaI-SalI DNA fragment containing the Syn
promoter was inserted into the NheI-SalI sites of the pEGFP-N1
(Clontech) and the resulting plasmid was designated pSyn-EGFP. A
685bp Cav1 cDNA was isolated from the pCRII-TOPO vector
(Invitrogen) by PmeI-NotI digest and inserted into the SmaI-NotI
site of the pSyn-EGFP to generate the pSyn-Cav1, in which the
EGFP gene was replaced with the Cav1 cDNA. The Syn-promoter-
Cav1cassettewasisolatedfromthe pSyn-Cav1andinsertedintothe
BamHI site of the HIV1 vector backbone plasmid pHIV7 [83] and
the resulting plasmid was designated pHIV1-Syn-Cav1.
Statistics Analysis
All parametric data were analyzed by unpaired t-tests or
ANOVA Bonferroni’s Multiple Comparison as appropriate; post
hoc comparisons were made by Student Neuman Keuls tests.
Significance was set at p,0.05. Statistical analysis was performed
using Prism 4 (GraphPad Software, Inc., La Jolla, CA).
appears to be the presence of more glia and glial scar formation within the dentate gyrus of Cav-1 KO mice as indicated by the darker gray cell bodies
intermixed with the neurons. (D) Hippocampal coronal cryostat sections (10 mm) from WT and Cav-1 KO mice were stained with Nissl (neuronal
marker, red pixels) and GFAP (astrocyte marker, green) to show no overlap between neurons and astrocytes. (E) Coronal cryostat sections (25 mm) of
2 month WT, 2 month Cav-1 KO and 12 month Cav-1 KO stained with 0.0004% Flouro-JadeHB and fluorescent red Nissl with DAPI. Areas from CA1 of
the hippocampus were imaged. WT CA1 showed well-organized astrocytes. Two month Cav-1 KO had areas of disorganized astrocytes with lightly
labeling areas of potential future plaque development. Twelve month Cav-1 KO CA1 areas had large bright, entangled green fluorescence with red
neurons inside and significantly less organized astrocytes, further demonstrating a degenerating neuronal model.
doi:10.1371/journal.pone.0015697.g005
Figure 6. Cav-1 KO mice have reduced hippocampal synapses. Synapses were quantified by routine electron microscopy as previously
described [82]. EM analysis revealed a significant reduction in hippocampal synapses in both (C) Cav-1 KO (Yg) and (B) Ag mice compared to (A) WT.
Synapses are indicated by red circles in WT, blue circles in Ag, and green circles in Cav-1 KO. (D) WT micrographs exhibited dendritic processes
(indicated by d) with intact cytoskeletal architecture (arrows and arrowheads), while (E) Ag and (F) Cav-1 KO displayed less organized dendritic shafts
(asterisk) with more abundant astrocyte presence (arrows). (G) Quantitation of data.
doi:10.1371/journal.pone.0015697.g006
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